Combined hepatitis A and B vaccines

descriptionPublicationkeyboard_double_arrow_right Article 01 Nov 1997 English Publisher:BMJJournal:Drug and Therapeutics Bulletin, volume 35, pages 84-86 (issn: 0012-6543, eissn: 1755-5248,

doi: 10.1136/dtb.1997.351184

pmid: 9464003

Combined hepatitis A and B vaccines

- Summary
- Subjects
- Metrics

Abstract

Within the last decade, the development of effective monovalent vaccines has provided a major advance in the prevention of both hepatitis A and B. We have previously reviewed these vaccines.1,2 Now, combined (bivalent) hepatitis A and B vaccines have been licensed (▼Twinrix Adult and ▼Twinrix Paediatric-SmithKline Beecham). Here we consider the potential uses for such combined vaccines.

Keywords

Adult, Viral Hepatitis Vaccines, Clinical Trials as Topic, Hepatitis A Vaccines, Hepatitis A, Hepatitis B, Risk Factors, Humans, Hepatitis B Vaccines, Vaccines, Combined, Child

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average